Nanotherapix

Description

Nanotherapix is a technology-based company with interests in the design and development of technologies, services, knowledge, molecules and products for application in the field of biotechnology and biomedicine. Is a collaboration of researchers from the Autonomous University of Barcelona and the Research Institute Foundation in Health Sciences Germans Trias i Pujol.

The objective is the development of advanced therapy medicinal products (ATMP) based on the use of autologous blood cells genetically modified ex vivo patient himself by a specific type of adenoviral vector.